HSBC HOLDINGS PLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$105,000
+31.2%
15,890
+33.1%
0.00%
Q3 2020$80,000
-30.4%
11,936
-13.7%
0.00%
Q2 2020$115,000
+3.6%
13,835
-4.7%
0.00%
Q1 2020$111,000
+12.1%
14,518
+21.6%
0.00%
Q4 2019$99,000
-1.0%
11,936
-11.8%
0.00%
Q3 2019$100,000
-55.0%
13,532
+39.2%
0.00%
Q2 2018$222,0009,7180.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders